ArticleClinical and molecular hepatology2014

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

Jeong Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.